SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: Steve Fancy who wrote (4192)5/4/1998 12:51:00 PM
From: John F Beule  Respond to of 6136
 
Todays' news is all about "angiogenesis inhibitors". as a layman, is the MMP inhibitors AGPH working on for cancer in the same class?



To: Steve Fancy who wrote (4192)5/4/1998 1:13:00 PM
From: PAL  Read Replies (1) | Respond to of 6136
 
Look at ENMD which has news about positive results on cancer treatment on mice. What would AGPH stock do if they have more postive news about that cancer development drugs?